+1-786-628-7980
Sign Up/Sign In 
FODMAP Friendly products cater up to 15% of the world’s population suffering from IBS (Irritable Bowel Syndrome) symptoms. Plant-based, Clean Label and Soy-Free Certifications by Else were successfully attained prior to the first product launch in the U.S. market.
VANCOUVER, BC, July 8, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announces it has attained FODMAP certification.
A FODMAP Friendly product ensures it is safe for those suffering from IBS symptoms. The FODMAP Friendly Certification Trademark is a globally registered Certification Trademark for low FODMAP packaged foods, certifying FODMAP levels in food products; laboratory tested, to be low in FODMAPs. FODMAP, short for Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols, are short-chain carbohydrates (sugars) the small intestine absorbs poorly. Approximately 1 in 7 people (or 15%, over 1 billion people globally) suffer IBS type symptoms – Approximately 15 times more people require a diet low in FODMAPs than a gluten-free diet.
“Wanting to support stomach wellness, attaining the FODMAP Certification was important as it gives our customers the assurance that Else products are safe for those with IBS symptoms,”
said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “It aligns with our product DNA of Clean Label, whole food nutrition that parents can feel good about providing to their children.” She added.
“FODMAP Friendly are so excited to partner with and certify Else Nutrition, the first FODMAP Friendly certified baby, toddler and children nutrition company in the world! Having been laboratory tested as low FODMAP and FODMAP Friendly certified, Else Nutrition is providing those with IBS globally the Confidence to Eat and Shop,” said Kiarra Martindale, Accredited Practicing Dietitian and Business Development and Marketing Manager of FODMAP Friendly.
This latest certification adds to Else Nutrition’s portfolio of distinguished certifications which include The Clean Label ProjectTM as well as certifications for being a Plant-Based Product, and Beyond Soy for being Soy-free.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was ranked last Fall as the #1 top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
For more information, contact:
Erin Jundef
Brilliant PR
E: Erinj@brilliantprm.com
Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: hamutaly@elsenutrition.com
P: +972(0)3-6445095
Mr. Sokhie Puar, Director of Else Nutrition
E : sokhiep@elsenutrition.com
P: 604-603-7787
US Investor Relations Contact
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
Email: shamsian@lythampartners.com
P: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
